Literature DB >> 12547721

Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction.

Ian P Crocker1, Suzanne Cooper, Stephen C Ong, Philip N Baker.   

Abstract

Placental apoptosis is increased in vivo in preeclampsia (PE) and intrauterine growth restriction (IUGR). The cause and pathological implications of this phenomenon are unknown. This study considers the apoptotic susceptibility of villous trophoblasts from normal, PE, and IUGR pregnancies. Cultured cytotrophoblasts (CTs) and an in vitro model of syncytialization were used. CTs were isolated from term placentas of 12 normal, 12 PE, and 12 IUGR pregnancies. Apoptosis was determined by terminal dUTP nick-end labeling (TUNEL), Annexin V binding, and ADP:ATP ratios. Cells were stimulated with tumor necrosis factor-alpha/interferon-gamma or reduced oxygen (<5 KPa). For CTs, ADP:ATP <1 correlates with Annexin V binding. For normal pregnancy, tumor necrosis factor-alpha and depleted oxygen significantly increased TUNEL, Annexin V binding and ADP:ATP in CTs and syncytiotrophoblasts (STs). Spontaneous apoptosis was similar between groups for both cell types. After stimulation, TUNEL and Annexin V binding of CTs were significantly raised in PE and IUGR as compared with normal pregnancy. After oxygen reduction, ADP:ATP in CTs and STs were significantly elevated in IUGR. TUNEL was also increased in STs in PE after oxygen depletion and was significantly raised in STs from IUGR pregnancies after stimulation with both agonists. This is the first description of enhanced apoptosis in isolated villous trophoblasts in PE and IUGR. These intrinsic differences may represent an important factor in the pathophysiology of these conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12547721      PMCID: PMC1851173          DOI: 10.1016/S0002-9440(10)63857-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes).

Authors:  T M Mayhew; L Leach; R McGee; W W Ismail; R Myklebust; M J Lammiman
Journal:  Placenta       Date:  1999 Jul-Aug       Impact factor: 3.481

2.  Placental apoptosis in normal human pregnancy.

Authors:  S C Smith; P N Baker; E M Symonds
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

3.  Circulating levels of immunoreactive cytokines in women with preeclampsia.

Authors:  K P Conrad; T M Miles; D F Benyo
Journal:  Am J Reprod Immunol       Date:  1998-08       Impact factor: 3.886

4.  Cellular proliferation in the placenta in normal human pregnancy and pregnancy complicated by intrauterine growth restriction.

Authors:  S C Smith; E Price; M J Hewitt; E M Symonds; P N Baker
Journal:  J Soc Gynecol Investig       Date:  1998 Nov-Dec

5.  Increased placental apoptosis in intrauterine growth restriction.

Authors:  S C Smith; P N Baker; E M Symonds
Journal:  Am J Obstet Gynecol       Date:  1997-12       Impact factor: 8.661

Review 6.  Checkpoints of dueling dimers foil death wishes.

Authors:  Z N Oltvai; S J Korsmeyer
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

7.  Studies of mesenchymal cells from 1st trimester human placenta: expression of cytokeratin outside the trophoblast lineage.

Authors:  T Haigh; C Chen; C J Jones; J D Aplin
Journal:  Placenta       Date:  1999-11       Impact factor: 3.481

8.  Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta.

Authors:  B Huppertz; H G Frank; J C Kingdom; F Reister; P Kaufmann
Journal:  Histochem Cell Biol       Date:  1998-11       Impact factor: 4.304

9.  Expression of the human p55 and p75 tumor necrosis factor receptors in primary villous trophoblasts and their role in cytotoxic signal transduction.

Authors:  J Yui; D Hemmings; M Garcia-Lloret; L J Guilbert
Journal:  Biol Reprod       Date:  1996-08       Impact factor: 4.285

10.  Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR.

Authors:  R R Adler; A K Ng; N S Rote
Journal:  Biol Reprod       Date:  1995-10       Impact factor: 4.285

View more
  54 in total

Review 1.  Determinants of fetal growth.

Authors:  David A Sacks
Journal:  Curr Diab Rep       Date:  2004-08       Impact factor: 4.810

2.  Fbxw8 is involved in the proliferation of human choriocarcinoma JEG-3 cells.

Authors:  Ping Lin; Jiejun Fu; Binjiahui Zhao; Feng Lin; Haifeng Zou; Leiyu Liu; Cheng Zhu; Hongmei Wang; Xiaoguang Yu
Journal:  Mol Biol Rep       Date:  2010-09-29       Impact factor: 2.316

3.  E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsia.

Authors:  L M Brown; H A Lacey; P N Baker; I P Crocker
Journal:  Histochem Cell Biol       Date:  2005-09-02       Impact factor: 4.304

4.  Disrupted placental serotonin synthetic pathway and increased placental serotonin: Potential implications in the pathogenesis of human fetal growth restriction.

Authors:  Suveena Ranzil; Stacey Ellery; David W Walker; Cathy Vaillancourt; Nadia Alfaidy; Alexander Bonnin; Anthony Borg; Euan M Wallace; Peter R Ebeling; Jan Jaap Erwich; Padma Murthi
Journal:  Placenta       Date:  2019-05-23       Impact factor: 3.481

5.  Maternal exposure to selenium and cadmium, fetal growth, and placental expression of steroidogenic and apoptotic genes.

Authors:  Todd M Everson; Maya Kappil; Ke Hao; Brian P Jackson; Tracy Punshon; Margaret R Karagas; Jia Chen; Carmen J Marsit
Journal:  Environ Res       Date:  2017-07-03       Impact factor: 6.498

6.  A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Samuel S Edwin; Ricardo Gomez; Lami Yeo; Agustin Conde-Agudelo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

7.  FAS and FAS-L genotype and expression in patients with recurrent pregnancy loss.

Authors:  Priscilla Chamelete Andrade Banzato; Silvia Daher; Evelyn Traina; Maria Regina Torloni; Bárbara Yasmin Gueuvoghlanian-Silva; Renata Fiorini Puccini; Karen Priscilla Tezotto Pendeloski; Rosiane Mattar
Journal:  Reprod Sci       Date:  2013-02-18       Impact factor: 3.060

8.  Differential effects of concomitant use of vitamins C and E on trophoblast apoptosis and autophagy between normoxia and hypoxia-reoxygenation.

Authors:  Tai-Ho Hung; Szu-Fu Chen; Meng-Jen Li; Yi-Lin Yeh; T'sang-T'ang Hsieh
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

9.  Decreased levels of folate receptor-β and reduced numbers of fetal macrophages (Hofbauer cells) in placentas from pregnancies with severe pre-eclampsia.

Authors:  Zhonghua Tang; Irina A Buhimschi; Catalin S Buhimschi; Serkalem Tadesse; Errol Norwitz; Tracy Niven-Fairchild; Se-Te J Huang; Seth Guller
Journal:  Am J Reprod Immunol       Date:  2013-03-11       Impact factor: 3.886

10.  Epidermal growth factor abrogates hypoxia-induced apoptosis in cultured human trophoblasts through phosphorylation of BAD Serine 112.

Authors:  Rachel G Humphrey; Christina Sonnenberg-Hirche; Steven D Smith; Chaobin Hu; Aaron Barton; Yoel Sadovsky; D Michael Nelson
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.